Neurogene Inc.
NGNE
$15.22
-$0.29-1.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.06% | 3.48% | -9.33% | -9.28% | -810.07% |
| Total Depreciation and Amortization | -4.51% | -1.12% | -1.22% | -0.97% | -0.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.33% | 64.93% | -51.79% | 122.68% | 107.50% |
| Change in Net Operating Assets | -57.81% | -134.96% | 391.58% | 86.98% | -58.84% |
| Cash from Operations | -18.74% | -12.41% | 2.07% | 26.59% | -27.56% |
| Capital Expenditure | -572.41% | 30.54% | 63.70% | -607.69% | 49.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.81% | -255.92% | -24.38% | -177.18% | 500.00% |
| Cash from Investing | 56.10% | -254.26% | -22.66% | -178.88% | 15.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.38% | -8.33% | 25.00% | -45.45% | -37.50% |
| Issuance of Common Stock | -99.99% | 132,821.68% | -65.54% | -34.02% | 62,800.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -107.57% |
| Cash from Financing | -100.00% | 144,987.79% | -67.17% | 106.12% | -106.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -194.08% | 257.56% | -13.53% | -2,320.78% | -98.29% |